ACUTE: Serelaxin showed no clear difference in death (any cause) compared with placebo (low certainty).
ACUTE: Serelaxin showed no clear difference in cardiovascular death compared with placebo (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
ACUTE: Serelaxin may leads to lower worsening heart failure compared with placebo (low certainty).
ACUTE: Serelaxin showed no clear difference in worsening kidney function compared with placebo (low certainty).
ACUTE: Serelaxin showed no clear difference in hypotension compared with placebo (low certainty).
It is very uncertain whether ACUTE: Serelaxin changes hyperkalaemia compared with placebo (very low certainty).
The review found no eligible studies for this question.